We would appreciate it if you could complete our website survey, open until 28 November 2025.
This item is authorised by the following title:
For transitional provisions relating to the repeal of this standard, see subsections 4(2) and (3) of the Therapeutic Goods (Poisons Standard—February 2023) Instrument 2022.
For transitional provisions relating to the repeal of this standard, see subsections 4(2) and (3) of the Therapeutic Goods (Poisons Standard—February 2023) Instrument 2022.